Fecha de vigencia | Policy Name | Reviewed Date |
6/16/2021 |
Abecma® (idecabtagene vicleucel)
| 4/19/2023 |
6/16/2021 |
Abecma® (idecabtagene vicleucel)
| 4/19/2023 |
1/1/2023 |
Abecma® (idecabtagene vicleucel)
| 4/19/2023 |
12/12/2018 |
Abilify MyCite® (aripiprazole tablets with sensor)
| 3/15/2023 |
12/12/2018 |
Abilify MyCite® (aripiprazole tablets with sensor)
| 3/15/2023 |
1/1/2021 |
Abilify® (aripiprazole)
| 8/16/2023 |
1/1/2023 |
Abraxane (nab- paclitaxel)
| 5/17/2023 |
1/1/2023 |
Abraxane (nab) paclitaxel
| 6/29/2023 |
1/1/2023 |
Abraxane (nab) paclitaxel
| 5/17/2023 |
7/21/2021 |
Accrufer™ (ferric maltol)
| 5/17/2023 |
1/1/2021 |
Acitretin
| 8/16/2023 |
1/1/2019 |
Actemra® (tocilizumab) Intravenous
| 9/20/2023 |
1/1/2019 |
Actemra® (tocilizumab) Intravenous
| 9/20/2023 |
1/1/2022 |
Actemra® (tocilizumab) Subcutaneous
| 9/20/2023 |
1/1/2022 |
Actemra® (tocilizumab) Subcutaneous
| 9/20/2023 |
1/1/2020 |
Actemra® IV (tocilizumab)
| 9/20/2023 |
1/1/2006 |
Actimmune® (interferon gamma-1b)
| 8/16/2023 |
1/1/2022 |
Actinic Keratosis Agents
| 8/16/2023 |
5/8/2020 |
Adakveo® (crizanlizumab-tmca)
| 2/15/2023 |
4/27/2022 |
Adbry™ (tralokinumab-ldrm)
| 4/19/2023 |
9/1/2011 |
Adcetris® (brentuximab vedotin)
| 2/16/2022 |
1/1/2021 |
Adempas® (riociguat)
| 3/15/2023 |
1/1/2022 |
ADHD Long Acting Stimulants
| 9/20/2023 |
1/1/2024 |
ADHD Long Acting Stimulants
| 9/20/2023 |
7/27/2022 |
Adlarity® (donepezil) transdermal patch
| 4/19/2023 |
1/1/2024 |
Adlarity® (donepezil) transdermal patch
| 6/21/2023 |
9/4/2023 |
Adstiladrin (nadofaragene firadenovec-vncg)
| 8/24/2023 |
12/15/2021 |
Aduhelm™ (aducanumab-avwa) intravenous solution
| 3/15/2023 |
4/27/2022 |
Aduhelm™ (aducanumab-avwa) intravenous solution
| 3/15/2023 |
1/1/2023 |
Aemcolo® (rifamycin)
| 3/15/2023 |
1/1/2024 |
Aemcolo® (rifamycin)
| 6/21/2023 |
1/1/2022 |
Afinitor/Afinitor Disperz (everolimus)
| 7/20/2022 |
1/1/2023 |
Afinitor/Afinitor Disperz (everolimus)
| 5/17/2023 |
1/1/2024 |
Afinitor/Afinitor Disperz (everolimus)
| 9/20/2023 |
1/1/2022 |
Aflibercept Products (Eylea®, Eylea® HD)
| 10/5/2023 |
1/1/2023 |
Aflibercept Products (Eylea®, Eylea® HD)
| 10/5/2023 |
12/31/2014 |
Afrezza® (insulin human) Inhalation Powder
| 3/15/2023 |
1/1/2017 |
Aggrenox® (aspirin/dipyridamole)
| 1/18/2023 |
5/26/2022 |
AHCA Continuity of Care
| 5/19/2022 |
10/25/2023 |
AIRSUPRA (albuterol and budesonide) inhalation aerosol
| 10/18/2023 |
11/15/2023 |
Akeega (niraparib and abiraterone acetate)
| 11/15/2023 |
1/1/2023 |
Aklief® (trifarotene)
| 5/17/2023 |
1/1/2020 |
Akynzeo (fosnetupitant/netupitant-palonosetron)
| 5/17/2023 |
1/1/2024 |
Akynzeo (fosnetupitant/netupitant-palonosetron)
| 6/21/2023 |
1/1/2013 |
Aldurazyme® (laronidase)
| 9/20/2023 |
1/1/2022 |
Alecensa (alectinib)
| 5/17/2023 |
1/1/2014 |
Alferon N® (interferon alfa-n3)
| 3/16/2022 |
12/20/2017 |
Aliqopa™ (copanlisib)
| 8/16/2023 |
12/9/2020 |
Alkindi® (hydrocortisone) sprinkle capsule
| 10/18/2023 |
1/1/2019 |
Allergy Ophthalmics
| 10/18/2023 |
1/1/2020 |
Allergy Ophthalmics
| 5/25/2023 |
1/1/2024 |
Allergy Ophthalmics
| 6/21/2023 |
1/1/2019 |
Aloxi (palonosetron)
| 2/23/2023 |
1/1/2016 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®)
| 9/20/2023 |
1/1/2024 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®)
| 7/19/2023 |
1/1/2023 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Zemaira®)
| 9/20/2023 |
1/1/2016 |
Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
| 9/20/2023 |
1/1/2024 |
Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
| 9/20/2023 |
1/1/2015 |
Alphagan® P (brimonidine)
| 7/19/2023 |
1/1/2024 |
Alphagan® P (brimonidine)
| 9/20/2023 |
7/20/2017 |
Alunbrig™ (brigatinib)
| 12/14/2022 |
1/1/2023 |
Amitiza® (lubiprostone)
| 5/17/2023 |
1/1/2024 |
Amitiza® (lubiprostone)
| 6/21/2023 |
6/16/2021 |
Amondys 45 (casimersen) intravenous solution
| 3/15/2023 |
1/1/2020 |
Ampyra® (dalfampridine)
| 10/18/2023 |
1/1/2020 |
Amrix®, Fexmid® (cyclobenzaprine hydrochloride)
| 2/15/2023 |
9/28/2022 |
Amvuttra™ (vutrisiran)
| 9/20/2023 |
1/1/2023 |
Amzeeq (minocycline) topical foam
| 5/17/2023 |
1/1/2020 |
Angiotensin Blocking & Renin Inhibitor Agents
| 5/17/2023 |
1/1/2024 |
Angiotensin Blocking & Renin Inhibitor Agents
| 8/16/2023 |
1/1/2023 |
Angiotensin Blocking Agents
| 5/17/2023 |
1/1/2019 |
Angiotensin-Calcium Channel Blocking Agents
| 1/18/2023 |
1/1/2022 |
Anticholinergics and Central Nervous System Polypharmacy Agents
| 8/17/2023 |
1/1/2020 |
Antidepressant Agents

| 11/15/2023 |
1/1/2019 |
Antipsychotic Utilization Program
| 3/15/2023 |
1/1/2020 |
Apadaz® (benzhydrocodone and acetaminophen)
| 2/15/2023 |
1/1/2022 |
Apokyn® (apomorphine) subcutaneous injection
| 6/21/2023 |
1/1/2020 |
Aptiom® (eslicarbazepine acetate)

| 11/15/2023 |
1/1/2024 |
Aptiom® (eslicarbazepine acetate)
| 6/21/2023 |
1/1/2023 |
Aranesp® (darbepoetin alfa)
| 7/19/2023 |
4/3/2008 |
Arcalyst® (rilonacept)
| 2/15/2023 |
1/1/2020 |
Arikayce® (liposomal amikacin for inhalation)
| 2/15/2023 |
12/11/2019 |
Asparlas™ (calaspargase pegol-mknl)

| 11/15/2023 |
1/1/2024 |
Astagraf XL (tacrolimus extended release)
| 8/16/2023 |
1/1/2019 |
Asthma Interleukin Inhibitors (Cinqair® , Nucala™, Fasenra®)
| 5/17/2023 |
1/1/2024 |
Atgam (antithymocyte immune globulin, equine)
| 6/21/2023 |
1/1/2013 |
Atgam® (antithymocyte immune globulin, equine)
| 6/21/2023 |
1/1/2023 |
Aubagio® (teriflunomide) tablet
| 3/16/2023 |
1/1/2023 |
Auryxia® (ferric citrate)
| 3/15/2023 |
1/1/2022 |
Austedo® & Austedo® XR (deutetrabenazine)
| 7/20/2023 |
11/30/2022 |
Auvelity™ (dextromethorphan and bupropion)
| 3/2/2023 |
6/17/2020 |
Avsola® (infliximab-axxq)
| 9/20/2023 |
1/1/2023 |
Avsola® (infliximab-axxq)
| 9/20/2023 |
1/1/2022 |
Avsola™ (infliximab-axxq)
| 9/20/2023 |
3/4/2020 |
Ayvakit™ (avapritinib)
| 7/19/2023 |
10/17/2018 |
Azedra® (iobenguano I 131)
| 3/15/2023 |
1/1/2022 |
Azilect® (rasagiline) tablets
| 1/18/2023 |
1/1/2019 |
Azopt® (brinzolamide ophthalmic suspension) 1%
| 10/18/2023 |
1/1/2024 |
Azopt® (brinzolamide ophthalmic suspension) 1%
| 9/20/2023 |